February 24, 2013
The National Institute of Biomedical Imaging and Bioengineering at the National Institute of Health (NIH) has announced that it will provide CU Boulder with a $4.4M Biotechnology Research Partnership grant to study aggregation of therapeutic protein molecules. The Research Partnership is headed by ChBE Prof. Ted Randolph and includes ChBE Prof. Dan Schwartz, Prof.
February 15, 2013
Chemical and Biological Engineering (ChBE) Associate Professor and Patten Fellow Ryan Gill and his team have been awarded $9.2 million from the U.S. Department of Energy (DOE) for research aimed at engineering E. coli to produce biofuels such as ethylene and isobutanol.
February 14, 2013
How do cohesive particles in fluidized beds interact, and how does this affect the functioning of the beds? This fundamental question is of great practical interest to a number of industries, leading an international chemical company to award a grant of $1.5M to ChBE Professor Christine Hrenya, along with collaborators Al Weimer and
February 13, 2013
February 7, 2013
February 5, 2013
Assistant Professor Anushree Chatterjee's research focuses on adopting integrated computational, systems and synthetic biology approaches to investigate fundamental, biotechnological and medically relevant issues including understanding the molecular mechanisms responsible for antibiotic and antiviral resistance, rational design of “next-generation smart antimicrobials,” and construction of synthetic genetic devices for a variety of biotechnological and bioenergy applications
January 21, 2013
Never one to sit still, Chemical and Biological Engineering Instructor Charlie Nuttelman has spent the past several summers writing a guidebook on hiking, mountain biking, snowshoeing, and cross country skiing. His book, titled Colorado Adventure Guide (Northern Edition), recently won a 2012 Writer's Digest Self-Publishing 1st Place Award and was featured in the De
January 3, 2013
November 16, 2012
BaroFold Inc., a pharmaceutical company focused on the patented Pressure Enabled Protein Manufacturing (PreEMT) technology invented in the labs of ChBE Professor Theodore Randolph and Dr. John Carpenter, has recently licensed its technology to both Boehringer Ingelheim and Nuron Biotech. Read more about these collaborative efforts below:
October 31, 2012
Ten active companies have been created since 1997 based on technologies invented wholly or in part by CU chemical and biological engineering students and their faculty supervisors. Chemical and biological engineering spinoff companies from CU-Boulder have raised nearly $410 million in follow-on funding, including grants, venture capital financing, U.S. Small Business Administration funding, and acquisitions, according to CU's Technology Transfer Office.